| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/02/2002 | WO2002034255A1 Granular drug preparations containing branched amino acids and process for producing the same |
| 05/02/2002 | WO2002034252A1 Drug composition comprising dipeptydyl aldehyde derivative |
| 05/02/2002 | WO2002034250A1 Fat emulsions |
| 05/02/2002 | WO2002034245A2 Use of tolterodine to treat asthma |
| 05/02/2002 | WO2002034240A2 Delayed and sustained release formulations and method of use thereof |
| 05/02/2002 | WO2002034239A1 Use of hydrophilic particles associated with antigens for preparing vaccine compositions |
| 05/02/2002 | WO2002034238A2 Colored gelatin-based formulations and method |
| 05/02/2002 | WO2002034237A1 Active agent delivery systems and methods for protecting and administering active agents |
| 05/02/2002 | WO2002034236A2 Lipid formulations for target delivery |
| 05/02/2002 | WO2002034235A1 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| 05/02/2002 | WO2002034234A2 Methylphenidate modified release formulations |
| 05/02/2002 | WO2002034232A2 Use of carotenoids for treating ageing symptoms |
| 05/02/2002 | WO2002034231A2 Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid |
| 05/02/2002 | WO2002034206A2 Felodipine transdermal device and methods |
| 05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | WO2002034200A2 Transdermal therapeutic systems comprising photosensitive active substances |
| 05/02/2002 | WO2002034113A2 Methods and instruments for treating pseudoarthrosis |
| 05/02/2002 | WO2002034031A1 Apparatus and method for delivering a beneficial agent |
| 05/02/2002 | WO2002011710A3 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 05/02/2002 | WO2002005822A3 Compositions containing therapeutically active components having enhanced solubility |
| 05/02/2002 | WO2002002103A3 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 05/02/2002 | WO2001095877A3 Porous celecoxib matrices and methods of manufacture thereof |
| 05/02/2002 | WO2001093837A3 Protein powder for pulmonary delivery |
| 05/02/2002 | WO2001092401A3 Highly flexible starch-based films |
| 05/02/2002 | WO2001091803A3 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 05/02/2002 | WO2001089489A3 Transdermal application of active agents directly via the carotid artery |
| 05/02/2002 | WO2001069244A3 Method for labeling individual cells |
| 05/02/2002 | WO2001062264A3 Halotherapy method by inhalation of sodium chloride |
| 05/02/2002 | WO2001056544A3 Shell-and-core dosage form approaching zero-order drug release |
| 05/02/2002 | WO2001052823A3 Compositions to effect the release profile in the transdermal administration of drugs |
| 05/02/2002 | WO2001049280A3 Weight promoting composition, method, and product |
| 05/02/2002 | WO2001045667A3 Water-soluble powders for oral solution and use thereof |
| 05/02/2002 | WO2001039762A3 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |
| 05/02/2002 | WO2001035949A3 Treatment or systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 05/02/2002 | WO2001032181A3 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| 05/02/2002 | WO2001028525A3 Method of producing sub-micron particles of biologically active agents |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001011068A3 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 05/02/2002 | WO2001008671A3 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 05/02/2002 | WO2000059491A3 Methods for modulating the human sexual response |
| 05/02/2002 | US20020052573 Device for controlled anaesthesia, analgesia and/or sedation |
| 05/02/2002 | US20020052518 Taxane with a hydrocarbon having at the alpha position a group such as halogen at the 2' and/or 7 positions; enhanced in vivo hydrolysis for enhanced taxane therapeutic activity |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052471 Human procalcitonin and the preparation and use thereof |
| 05/02/2002 | US20020052422 Oral drug delivery compositions and methods |
| 05/02/2002 | US20020052421 Using mixture of water-insoluble carotenoid crystal and medium chain fatty acid triglyceride (MCT) as a core substance |
| 05/02/2002 | US20020052419 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens and method of inhibiting terpenoid adsorption |
| 05/02/2002 | US20020052411 Valproate compositions and processes for making |
| 05/02/2002 | US20020052404 Compositions and methods for treating or preventing diseases of body passageways |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052390 Treating non-invasive fungus-induced otitis media by mucoadministering an antifungal agent. |
| 05/02/2002 | US20020052367 Pharmaceutical compositions containing carvedilol and hydrochlorothiazide |
| 05/02/2002 | US20020052366 Administering taurolidine, taurultam, or a biologically active derivative; induces tumor cell death by apoptosis. |
| 05/02/2002 | US20020052341 Bupropion metabolites and methods of their synthesis and use |
| 05/02/2002 | US20020052320 Sustained peptide-release formulation |
| 05/02/2002 | US20020052310 Bioactive agent in association with a charged lipid wherein the charged lipid has an overall net charge which is opposite to the overall net charge of the agent upon association and wherein release of the agent is sustained. |
| 05/02/2002 | US20020051883 Processing and manufacturing methods enabled using non-stoichiometric nanomaterials |
| 05/02/2002 | US20020051824 Contacting an area of the skin showing symptoms of the hyperproliferative skin disorder such as psoriasis with silver or other noble metals in a nanocrystalline form |
| 05/02/2002 | US20020051821 Gelled alginate particles suitable for administration by needleless injection are loaded with a pharmacologically active agent and have a mean mass aerodynamic diameter of from 0.1 to 250 mu m and envelop density from 0.1 to 2.5 g/cm3 |
| 05/02/2002 | US20020051820 Polymeric matrix swells upon imbibition of water thereby attaining a size large enough to promote retention in stomach during feeding mode, that releases drug into gastric fluid by dissolution and diffusion of the drug out of matrix |
| 05/02/2002 | US20020051818 A core in the form of a tablet and having an enteric coating surrounding core, comprising an acid labile medicament, a binder or filler, a disintegrant and a lubricant, coating is formed of methacrylic acid copolymer and plasticizer |
| 05/02/2002 | US20020051817 Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof |
| 05/02/2002 | US20020051816 Beta-lactam antibiotic-containing tablet and production thereof |
| 05/02/2002 | US20020051815 Administering to a apnea disorder patient a therapeutically effective amount of R(+) ondansetron, or its hydrochloric salt, substantially free of its S(-) stereoisomer |
| 05/02/2002 | US20020051814 Composition for the treatment and prevention of ischemic events |
| 05/02/2002 | US20020051813 Lipomatrix comprises atleast one phospholipid and composed of lipid lattices of stacked bilayers which, when hydrated, form liposomes, useful for producing highly potent vaccines against tumor antigens |
| 05/02/2002 | US20020051812 Drug delivery via therapeutic hydrogels |
| 05/02/2002 | US20020051811 Method and composition for masking mineral taste |
| 05/02/2002 | US20020051809 Such as monensin, antifoam agent(s), wetting and/or surfactant agent(s), dispersal agent(s), and suspension agent(s); suspension in water alone or in conjunction with a milk replacer for a calf feed |
| 05/02/2002 | US20020051808 Drug delivery system involving interaction between protein or polypeptide and hydrophobic biodegradable polymer |
| 05/02/2002 | US20020051807 Controlled release alprazolam in the core optionally in combination with an anti-psychotic agent, in a rapid release external coat; smaller, easier to swallow |
| 05/02/2002 | US20020051803 Lotions containing vitamin D3 derivatives |
| 05/02/2002 | US20020051802 Rod-shaped mesoporous powder, humectant adsorbing powder, and cosmetic preparation using the same |
| 05/02/2002 | US20020051797 Of a hydrophilic polymer emulsion and a hydrophobic polymer emulsion; use to protect skin from irritants, chemical or pathogenic |
| 05/02/2002 | US20020051787 Steroids, viricides, and anti-microbial neutralizing antibodies suspended in a carrier |
| 05/02/2002 | US20020051776 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/02/2002 | US20020051775 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051774 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/02/2002 | US20020051773 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051772 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051771 Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders |
| 05/02/2002 | US20020051758 Clear antiperspirants and deodorants made with siloxane-based polyamides |
| 05/02/2002 | US20020051753 Comprising a pressure-sensitive adhesive layer containing a drug on a cloth which prevents the dilution of drug by saliva |
| 05/02/2002 | US20020051752 Tablet comprising: the active ingredient; an acid and an alkali such as sodium glycine carbonate manufactured by direct compression in normal thermohygrometric conditions and with standard tabletting equipment |
| 05/02/2002 | US20020051749 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 05/02/2002 | US20020051748 External aqueous phase contains a thixotropic inorganic salt, such as aluminum hydroxide or alum; helps to elicit a response from the subject's immune system, and stabilize emulsion; shelf life |
| 05/02/2002 | US20020050660 Liposome extrusion process |
| 05/02/2002 | US20020050659 Extruding liquid core with polymerizable liquid through concentric nozzles forming droplets, then heating to polymerize outer layer; useful as artificial diet capsules in beneficial insect rearing; biological pest control |
| 05/02/2002 | EP1201709A1 Coprocessed granules of disintegrating agents |
| 05/02/2002 | EP1201251A1 Stratified and cryogenically stored vaccines, process for their preparation |
| 05/02/2002 | EP1201249A1 Suspension of EPI-HNE-4, dry powder aerosol derived therefrom, process of preparation thereof, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 05/02/2002 | EP1201242A2 Use of mometasone furoate in an adjuvant therapy |
| 05/02/2002 | EP1201233A1 Transdermal dosage form |
| 05/02/2002 | EP1201232A1 Patches for external use |
| 05/02/2002 | EP1201231A2 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency |
| 05/02/2002 | EP1201230A2 Solution-based transdermal drug delivery system comprising a vasodilator |
| 05/02/2002 | EP1201220A1 Cosmetic or pharmaceutical compositions containing thermostabilising microcapsules |
| 05/02/2002 | EP1201219A1 Use of thermostabilising microcapsules for improving the activity or the penetration of cosmetic or pharmaceutical active agents |
| 05/02/2002 | EP1201209A2 Vaginal discharge collection and drug delivery device |
| 05/02/2002 | EP1201138A1 Carotenoid beads |